Xiangyu Zhai

753 total citations · 2 hit papers
28 papers, 525 citations indexed

About

Xiangyu Zhai is a scholar working on Surgery, Hepatology and Cancer Research. According to data from OpenAlex, Xiangyu Zhai has authored 28 papers receiving a total of 525 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Surgery, 8 papers in Hepatology and 8 papers in Cancer Research. Recurrent topics in Xiangyu Zhai's work include Liver Disease Diagnosis and Treatment (6 papers), Cancer-related molecular mechanisms research (5 papers) and MicroRNA in disease regulation (4 papers). Xiangyu Zhai is often cited by papers focused on Liver Disease Diagnosis and Treatment (6 papers), Cancer-related molecular mechanisms research (5 papers) and MicroRNA in disease regulation (4 papers). Xiangyu Zhai collaborates with scholars based in China, Germany and United States. Xiangyu Zhai's co-authors include Bin Jin, Huaxin Zhou, Zhijia Xia, Gang Du, Hao Zhang, Tong Xia, Zhengchen Jiang, Wei Wang, Dandan Dou and Zhipeng Li and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and ACS Nano.

In The Last Decade

Xiangyu Zhai

23 papers receiving 516 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

KIF18A inactivates hepatic stellate cells and alleviates liver fibrosis through the TTC3/Akt/mTOR pathway

2024 61 citations Hao Zhang, Zhijia Xia et al. Cellular and Molecular Life Sciences profile →
Oxytocin alleviates liver fibrosis via hepatic macrophages

2024 46 citations Xiangyu Zhai, Hao Zhang et al. JHEP Reports profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Xiangyu Zhai China	14	253	147	120	111	84	28	525
Morteza Aghmesheh Australia	14	177 0.7×	181 1.2×	376 3.1×	74 0.7×	127 1.5×	65	695
Tianli Cheng China	12	194 0.8×	138 0.9×	150 1.3×	89 0.8×	109 1.3×	25	493
Dong Fang China	10	303 1.2×	95 0.6×	107 0.9×	134 1.2×	11 0.1×	35	526
Yiqing Cai China	15	292 1.2×	142 1.0×	91 0.8×	100 0.9×	83 1.0×	53	598
Guan‐Ting Liu Taiwan	12	192 0.8×	87 0.6×	87 0.7×	61 0.5×	39 0.5×	33	461
Deze Zhao China	14	234 0.9×	128 0.9×	130 1.1×	65 0.6×	152 1.8×	22	475
Jiaxiang Du China	13	291 1.2×	129 0.9×	154 1.3×	39 0.4×	62 0.7×	32	565
Wensheng Qiu China	13	250 1.0×	123 0.8×	113 0.9×	53 0.5×	132 1.6×	41	480
Xin Fan China	15	274 1.1×	128 0.9×	100 0.8×	88 0.8×	95 1.1×	38	551
Shuxin Sun China	17	300 1.2×	190 1.3×	227 1.9×	103 0.9×	64 0.8×	46	803

Countries citing papers authored by Xiangyu Zhai

Since Specialization

Citations

This map shows the geographic impact of Xiangyu Zhai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiangyu Zhai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiangyu Zhai more than expected).

Fields of papers citing papers by Xiangyu Zhai

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiangyu Zhai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiangyu Zhai. The network helps show where Xiangyu Zhai may publish in the future.

Co-authorship network of co-authors of Xiangyu Zhai

This figure shows the co-authorship network connecting the top 25 collaborators of Xiangyu Zhai. A scholar is included among the top collaborators of Xiangyu Zhai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiangyu Zhai. Xiangyu Zhai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhai, Xiangyu, Kecheng Li, Yanmei Wu, et al.. (2025). Identification of anoikis-related subtypes and a risk score prognosis model, the association with TME landscapes and therapeutic responses in hepatocellular carcinoma. Frontiers in Immunology. 16. 1602831–1602831.

Zhang, Hao, Haoran Qu, Yi Gao, et al.. (2025). MYCBP2-mediated HNF4α ubiquitination reprogrammed lipid metabolism in MASH-associated hepatocellular carcinoma. Oncogene. 44(24). 1961–1974.

Du, Gang, Zhaochen Jiang, Tong Xia, et al.. (2024). lincRNA00907 promotes NASH progression by targeting miRNA-942-5p/TAOK1. Aging. 16(8). 6868–6882.

Yang, Mengfan, Xiangyu Zhai, Xinyu Yang, et al.. (2024). Integrated multi-omic analysis identifies fatty acid binding protein 4 as a biomarker and therapeutic target of ischemia–reperfusion injury in steatotic liver transplantation. Cellular and Molecular Life Sciences. 81(1). 83–83. 5 indexed citations

Zhang, Hao, Zhijia Xia, Huaxin Zhou, et al.. (2024). KIF18A inactivates hepatic stellate cells and alleviates liver fibrosis through the TTC3/Akt/mTOR pathway. Cellular and Molecular Life Sciences. 81(1). 61 indexed citations breakdown →

Zhang, Haopeng, et al.. (2024). Mechanism Analysis of the Effect of the Equivalent Proportional Coefficient of Inertia Control for a Doubly Fed Wind Generator on Frequency Stability in Extreme Environments. Sustainability. 16(12). 4965–4965. 19 indexed citations

Yang, Mengfan, Xuyong Wei, Xiangyu Zhai, et al.. (2024). Influence of intraoperative blood salvage and autotransfusion on tumor recurrence after deceased donor liver transplantation: a large nationwide cohort study. International Journal of Surgery. 110(9). 5652–5661.

Zhai, Xiangyu, Hao Zhang, Zhijia Xia, et al.. (2024). Oxytocin alleviates liver fibrosis via hepatic macrophages. JHEP Reports. 6(6). 101032–101032. 46 indexed citations breakdown →

Wang, Zixiang, Jing Wang, Jianping Song, et al.. (2023). Spliceosome component Usp39 contributes to hepatic lipid homeostasis through the regulation of autophagy. Nature Communications. 14(1). 7032–7032. 9 indexed citations

10.

Li, Zhipeng, Huaxin Zhou, Zhijia Xia, et al.. (2023). HMGA1 augments palbociclib efficacy via PI3K/mTOR signaling in intrahepatic cholangiocarcinoma. Biomarker Research. 11(1). 33–33. 40 indexed citations

11.

Zhai, Xiangyu, et al.. (2023). Development and validation of prognostic risk prediction models for hepatocellular carcinoma patients treated with immune checkpoint inhibitors based on a systematic review and meta-analysis of 47 cohorts. Frontiers in Immunology. 14. 1215745–1215745. 7 indexed citations

12.

Li, Zhipeng, Huaxin Zhou, Xiangyu Zhai, et al.. (2023). MELK promotes HCC carcinogenesis through modulating cuproptosis-related gene DLAT-mediated mitochondrial function. Cell Death and Disease. 14(11). 733–733. 58 indexed citations

13.

Wang, Wei, Wendong Liu, Xia Tong, et al.. (2023). Two-photon excited luminescence of structural light enhancement in subwavelength SiO2 coating europium ion-doped paramagnetic gadolinium oxide nanoparticle and application for magnetic resonance imaging. Discover Nano. 18(1). 85–85. 3 indexed citations

14.

Jiang, Zhengchen, Gang Du, Xiangyu Zhai, et al.. (2022). Laparoscopic versus open surgery for hepatic caudate lobectomy: a retrospective study. Surgical Endoscopy. 37(2). 1149–1156. 2 indexed citations

15.

Zhai, Xiangyu, Zhijia Xia, Tong Xia, et al.. (2022). LRP1B suppresses HCC progression through the NCSTN/PI3K/AKT signaling axis and affects doxorubicin resistance. Genes & Diseases. 10(5). 2082–2096. 40 indexed citations

16.

Dou, Dandan, Xiangyu Zhai, Guosheng Li, et al.. (2021). Oxytocin signalling in dendritic cells regulates immune tolerance in the intestine and alleviates DSS-induced colitis. Clinical Science. 135(4). 597–611. 21 indexed citations

17.

Luo, Dan, Bin Jin, Xiangyu Zhai, et al.. (2021). Oxytocin promotes hepatic regeneration in elderly mice. iScience. 24(2). 102125–102125. 16 indexed citations

18.

Tian, Yi, et al.. (2019). Bevacizumab in Combination with Pemetrexed and Platinum Significantly Improved the Clinical Outcome of Patients with Advanced Adenocarcinoma NSCLC and Brain Metastases. SHILAP Revista de lepidopterología. 1 indexed citations

19.

Zhai, Xiangyu, Wei Wang, Dandan Dou, et al.. (2019). A novel technique to prepare a single cell suspension of isolated quiescent human hepatic stellate cells. Scientific Reports. 9(1). 12757–12757. 16 indexed citations

20.

Jiang, Zhengchen, et al.. (2018). KIAA1199 overexpression is associated with abnormal expression of EMT markers and is a novel independent prognostic biomarker for hepatocellular carcinoma. OncoTargets and Therapy. Volume 11. 8341–8348. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact